NEPHROLOGY / CLINICAL RESEARCH
Causal association between sleep traits and diabetic nephropathy
More details
Hide details
1
General Practice, Changshou Street Community Health Service Hospital, Shanghai,
China
Submission date: 2025-02-08
Final revision date: 2025-07-22
Acceptance date: 2025-07-23
Online publication date: 2025-09-20
Corresponding author
Chunyang Zhang
General Practice
Community Health
Service Hospital
Changshou Street
Shanghai, China
KEYWORDS
TOPICS
ABSTRACT
Introduction:
The study aimed to explore the causal association between genetically predicted sleep traits (chronotype, sleep duration, short sleep duration, long sleep duration, insomnia, daytime sleepiness, and sleep apnea syndrome) and diabetic nephropathy (DN).
Material and methods:
A two-sample Mendelian randomization (MR) design was used to analyze summary data from genome-wide association studies of sleep traits and DN. The main analysis was conducted using the inverse variance weighted (IVW) method, and robustness was tested using the weighted median, weighted mode, and MR-Egger regression methods. Heterogeneity was detected using Cochran’s Q-test, horizontal pleiotropy using the MR-Egger regression method, potential outliers using MR-PRESSO, and single-nucleotide polymorphisms driving the results using a leave-one-out analysis.
Results:
The genetic prediction results indicated no statistically significant associations between the sleep traits and DN (all IVW p > 0.05). However, the weighted median analysis showed a possible causal association between long sleep and DN (OR < 0.01, 95% CI: 0–0.70, p = 0.04) and a borderline possible causal association between sleep apnea syndrome and DN (OR = 2.50, 95% CI: 0.99–6.35, p = 0.05). Cochran’s Q-test indicated possible heterogeneity for the sleep duration analysis (p = 0.01), but no horizontal pleiotropy or outliers were detected (all p > 0.05).
Conclusions:
This MR analysis suggested no causal associations between the sleep traits (chronotype, sleep duration, short sleep duration, long sleep duration, insomnia, daytime sleepiness, and sleep apnea syndrome) and DN. Further in-depth research is needed to examine the relationship between sleep and DN.
REFERENCES (29)
1.
Rao LV/Rao LBV, Tan SH, Candasamy M, Bhattamisra SK. Diabetic nephropathy: an update on pathogenesis and drug development. Diabetes Metab Syndr 2019; 13: 754-62.
2.
American Diabetes Association Professional Practice C. Introduction and Methodology: Standards of Care in Diabetes-2024. Diabetes Care 2024; 47 Suppl 1: S1-4.
3.
Brinkman JE, Reddy V, Sharma S. Physiology of Sleep. StatPearls. Treasure Island (FL) ineligible companies. 2024.
4.
Lien ASY, Jiang YD, Tsai JL, Hwang JS, Lin WC. Prediction of diabetic nephropathy from the relationship between fatigue, sleep and quality of life. Appl Sci 2020; 10: 3282.
5.
Zamarron E, Jaureguizar A, Garcia-Sanchez A, et al. Obstructive sleep apnea is associated with impaired renal function in patients with diabetic kidney disease. Sci Rep 2021; 11: 5675.
6.
Misra A, Shrivastava U. Obstructive sleep apnea and diabetic nephropathy. Diabetes Technol Ther 2016; 18: 405-7.
7.
Liu C, Zhang J, Wei X, et al. Effects of sleep duration and changes in body mass index on diabetic kidney disease: a prospective cohort study. Front Endocrinol (Lausanne) 2023; 14: 1278665.
8.
Zamarron E, Jaureguizar A, Garcia-Sanchez A, et al. Continuous positive airway pressure effect on albuminuria progression in patients with obstructive sleep apnea and diabetic kidney disease: a randomized clinical trial. Am J Respir Crit Care Med 2023; 207: 757-67.
9.
Haycock PC, Burgess S, Wade KH, Bowden J, Relton C, Davey Smith G. Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies. Am J Clin Nutr 2016; 103: 965-78.
10.
Jones SE, Lane JM, Wood AR, et al. Genome-wide association analyses of chronotype in 697,828 individuals provides insights into circadian rhythms. Nat Commun 2019; 10: 343.
11.
Wang H, Lane JM, Jones SE, et al. Genome-wide association analysis of self-reported daytime sleepiness identifies 42 loci that suggest biological subtypes. Nat Commun 2019; 10: 3503.
12.
Campos AI, Ingold N, Huang Y, et al. Discovery of genomic loci associated with sleep apnea risk through multi-trait GWAS analysis with snoring. Sleep 2023; 46: zsac308.
13.
Jansen PR, Watanabe K, Stringer S, et al. Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways. Nat Genet 2019; 51: 394-403.
14.
Wang J, Sun Z, Zhong Y, et al. Sleep disturbances and heart failure: observational study and mendelian randomization study. Arch Med Sci 2024; 21: 1222-32.
15.
Wang Y, Liu S, Wu C, Yu H, Ji X. Association between circulating unsaturated fatty acid and preeclampsia: a two-sample Mendelian randomization study. J Matern Fetal Neonatal Med 2024; 37: 2294691.
16.
Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 2013; 37: 658-65.
17.
Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 2015; 44: 512-25.
18.
Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 2016; 40: 304-14.
19.
Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol 2017; 46: 1985-98.
20.
Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan N, Thompson J. A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med 2017; 36: 1783-802.
21.
Chaput JP, Dutil C, Featherstone R, et al. Sleep duration and health in adults: an overview of systematic reviews. Appl Physiol Nutr Metab 2020; 45: S218-31.
22.
Wang D, Li W, Cui X, et al. Sleep duration and risk of coronary heart disease: asystematic review and meta-analysis of prospective cohort studies. Int J Cardiol 2016; 219: 231-9.
23.
Shan Z, Ma H, Xie M, et al. Sleep duration and risk of type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 2015; 38: 529-37.
24.
Alterki A, Abu-Farha M, Al Shawaf E, Al-Mulla F, Abubaker J. Investigating the relationship between obstructive sleep apnoea, inflammation and cardio-metabolic diseases. Int J Mol Sci 2023; 24: 6807.
25.
Dzierzewski JM, Donovan EK, Kay DB, Sannes TS, Bradbrook KE. Sleep inconsistency and markers of inflammation. Front Neurol 2020; 11: 1042.
26.
Matoba K, Takeda Y, Nagai Y, Kawanami D, Utsunomiya K, Nishimura R. Unraveling the role of inflammation in the pathogenesis of diabetic kidney disease. Int J Mol Sci 2019; 20: 3393.
27.
Buyukaydin B, Akkoyunlu ME, Kazancioglu R, et al. The effect of sleep apnea syndrome on the development of diabetic nephropathy in patients with type 2 diabetes. Diabetes Res Clin Pract 2012; 98: 140-3.
28.
Farhud DD. Hypothetical strategies of gene and environmental influence on life expectancy: a brief review. Iran J Public Health 2022; 51: 2382-7.
29.
Pierce BL, Burgess S. Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol 2013; 178: 1177-84.